Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
37 hedge funds and large institutions have $17.9M invested in Fibrocell Science Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less funds holding
Funds holding: 44 → 37 (-7)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
43% less capital invested
Capital invested by funds: $31.4M → $17.9M (-$13.5M)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$51.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.9K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$10.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$1.43M |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$398K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$167K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$111K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$101K |
FCSC Hedge Fund Activity: Q3 2016 in Review
37 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2016, worth a combined $17.9M — down 43% from $31.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of FCSC and 4 opened new positions — a net loss of 7 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $51.5K. The largest seller was QVT Financial, cutting an estimated $1.43M.
- 37 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2016, down from 44 in Q2 2016.
- Funds reported $17.9M of Fibrocell Science Inc. stock for Q3 2016, down 43% quarter-over-quarter.
- 4 funds opened new Fibrocell Science Inc. positions in Q3 2016 and 11 closed out, a net change of -7 holders.
- The largest Fibrocell Science Inc. buyer in Q3 2016 was Renaissance Technologies, an estimated $51.5K added.
- The largest Fibrocell Science Inc. seller in Q3 2016 was QVT Financial, an estimated $1.43M sold.
Based on aggregated 13F filings for Q3 2016.